Assessment of the Ionizing Radiation Received During Percutaneous or Conventional Surgery of Hallux Valgus
NCT ID: NCT05174702
Last Updated: 2023-09-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
71 participants
OBSERVATIONAL
2022-01-05
2023-04-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Can Hypermobility of First Ray Affect Surgical Treatment of Hallux Valgus
NCT05051709
Hallux Valgus- Radiological and Clinical Predictors for Outcome After Surgery
NCT04851249
Measurement of Arch Motion After Bunion Surgery
NCT02074748
Tourniquet Use in Hallux Valgus Surgery
NCT06680518
Metatarsophalangeal Arthrodesis of the Hallux
NCT05691075
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients will be informed of the study during a preoperative visit. The data concerning them will be collected on the day of the surgery. No follow-up over time is necessary.
Passive "ring" and "cornea" dosimeters will be worn by healthcare professionals during procedures for patients included in the study. Their data will be collected each month and at the end of the study, and reported secondarily to the number of operations. Several surgeons, dressers and operating assistants will participate in the operations, their data will be aggregated taking into account their function and not individuals.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Percutaneous surgery
Patient will have a percutaneous hallus valgus surgery
Irradiation collected at the end of the operation on the active dosimeter
Mesure of the irradiation collected at the end of the operation on the active dosimeter for the surgeon, the patient and the operating team
conventional surgery
Patient will have a conventional hallus valgus surgery
Irradiation collected at the end of the operation on the active dosimeter
Mesure of the irradiation collected at the end of the operation on the active dosimeter for the surgeon, the patient and the operating team
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Irradiation collected at the end of the operation on the active dosimeter
Mesure of the irradiation collected at the end of the operation on the active dosimeter for the surgeon, the patient and the operating team
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient capable of understanding the information related to the study, of reading the information leaflet and having expressed his non-opposition to participating in the study.
Exclusion Criteria
* Patient under guardianship or curatorship, or under a regime of deprivation of liberty.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
GCS Ramsay Santé pour l'Enseignement et la Recherche
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinique Blomet
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-A02408-33
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.